All posts by imreal

How Knowledge Graphs Accelerate Drug Discovery in Biotechs, Upcoming Webinar Hosted by Xtalks


Additional challenges need to be addressed, such as lack of FAIR data, access to necessary resources and skills and internal change management.

The emergence of knowledge graphs, artificial intelligence (AI), machine learning and FAIR (Findable, Accessible, Interoperable and Reusable) data principles has created a unique opportunity within the biopharmaceutical industry to capitalize on the explosion of growth in data in the last 10 years. However, there remain significant barriers to adoption of these approaches, specifically in the biotech sector where there is a need to maximize cost effectiveness in choosing tools that get results fast and allow them to scale. There is a strong desire to investigate and leverage data science, AI and machine learning approaches in drug discovery and democratize insights across the organization. However, additional challenges need to be addressed, such as lack of FAIR data, access to necessary resources and skills and internal change management.

Attendees will gain insights into a unique knowledge management platform that harmonizes siloed, disparate data using a powerful data ingestion engine and underlying knowledge graph. The platform’s flexible user interface is customized to shield end-users from complexity which enables Aelin Therapeutics and e-therapeutics to democratize insights across their wider organization to support rapid, crucial research & development decision making to accelerate their drug discovery process.

In this webinar, attendees will hear from the CIO of Aelin Therapeutics, a biotech company that leverages targeted protein aggregation to develop a completely new class of therapeutics, aiming at hard-to-treat targets in cancer and infectious diseases, and the Head of Discovery Biology at e-therapeutics, a biotech company that integrates computational power and biology to discover life-transforming RNAi medicines. The featured speakers will discuss how they collaborate with ONTOFORCE, a Life Sciences technology company which transforms data into knowledge by unlocking hidden insights from data.

Register to learn how the adoption and usage of knowledge graphs, AI and machine learning approaches accelerates drug discovery.

Join James Longden, Head of Discovery Biology, e-therapeutics; and Paul Vauterin, CIO, Aelin Therapeutics, for the live webinar on Tuesday, September 27, 2022, at 9am EDT (3pm CEST/EU-Central).

For more information, or to register for this event, visit How Knowledge Graphs Accelerate Drug Discovery in Biotechs.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Few-Shot Prediction of Drug-Target Binding Affinities for Small Molecule Drug Discovery, Upcoming Webinar Hosted by Xtalks


Accurate prediction of the binding behavior between the target protein and the compounds is crucial for discovering the candidate molecule with decent potency and selectivity.

In the early stage of small molecule drug discovery, accurate prediction of the binding behavior between the target protein and the compounds is crucial for discovering the candidate molecule with decent potency and selectivity. In practical situations, drug-target binding affinity (DTA) prediction becomes difficult because of the lack of a precise protein structure model or known ligands. Data-driven methods are actively being used to conquer the problem. However, the available data is usually insufficient to build a model with generalization capability for the novel targets.

A promising approach to remedy these situations is a few-shot prediction of drug-target bindings, which relies on the small number of the known binding affinities of compounds. A neural process-based model for this purpose (MetaDTA) was recently developed, which does not use the structural information of the proteins. The method is based on meta-learning the known binding affinity values for various protein targets. The prediction accuracy is superior to the state-of-the-art structure-free prediction models, and the model is highly generalizable for unknown targets.

Join this webinar to learn about the proposed meta-learning approach for drug-target binding affinity prediction with the results, limitations and future perspectives.

Join Jiho Yoo, AI Director, Standigm Inc., for the live webinar on Monday, September 26, 2022, at 3pm EDT (12pm PDT).

For more information, or to register for this event, visit Few-Shot Prediction of Drug-Target Binding Affinities for Small Molecule Drug Discovery.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Moshe Zaghi Joins Home Care Provider Alvita Care as President


Alvita Care provides home care services to seniors in New York City, Long Island, Westchester, and New Jersey.

Alvita Care provides home care services to seniors in New York City, Long Island, Westchester, and New Jersey.

Having experienced the need for home care within my own family, and the difficulties associated with finding quality care, I have a deep sense of appreciation for the operations associated with care and the caregivers and nurses that make Alvita Care best-in-class

Alvita Care, a leading home care agency servicing New York and New Jersey, is pleased to announce that Moshe Zaghi has joined the Company as President effective, September 7, 2022.

In this newly created role, Mr. Zaghi will take primary responsibility for accelerating the Company’s operational performance and leading the Company’s transformative growth initiatives. “We are proud to have attracted the talent that Moshe brings to Alvita Care. He has the financial acumen and operational experience of successfully scaling high-touch businesses with a heavy focus on care. He joins Alvita Care at a critical juncture as we prepare to grow and scale aggressively,” said Alvita Care’s Founder and Chief Executive Officer, Tracy Ongena.

Mr. Zaghi brings several years of valuable professional experience within the field of healthcare and strategy consulting. Prior to joining Alvita Care, Mr. Zaghi served as Chief Financial Officer of Optima Dermatology Partners, an Alpine Investors portfolio company, where he had the opportunity to integrate, centralize, and professionalize Optima’s infrastructure, financial reporting, data visibility, and business processes to support rapid growth. During his time at Optima, the company doubled its geographic footprint, successfully entered eight new markets, and more than doubled its provider headcount, all while maintaining industry-leading patient satisfaction scores.

“Joining Alvita Care is more than a job for me. Having experienced the need for home care within my own family, and the difficulties associated with finding quality care, I have a deep sense of appreciation for the operations associated with care and the caregivers and nurses that make Alvita Care best-in-class,” said Mr. Zaghi.

“Mr. Zaghi’s success in scaling and professionalizing Optima will be a key factor as we build a team that can propel Alvita Care to its next phase of growth,” noted Ms. Ongena.

Prior to joining Optima, Mr. Zaghi was a Senior Manager at Bain & Company, a global management consulting firm, where he advised a range of healthcare, retail, technology services, and utility clients on growth strategy and performance improvement.

Mr. Zaghi holds an MBA from Stanford Graduate School of Business, where he graduated as an Arjay Miller Scholar, and a JD from Yale Law School. He graduated from Yeshiva University as valedictorian of the Sy Syms School of Business with a B.S. in Accounting.

About Alvita Care

Alvita Care is a leading, licensed home care agency (LHCSA) in New York and New Jersey that provides best-in-class Home Care, Private Duty Nursing, Care Management, and Bedside Care. The Alvita Care team comprises highly skilled and trained clinical professionals, including Registered Nurses, Certified Home Health Aides, Certified Nursing Assistants, Care Managers, and Care Coordinators – all taking a client-centered approach. Alvita Care provides customized care plans for each client’s needs, so the family members of our clients can rest assured knowing their loved ones are safe and receiving quality care. Alvita Care has earned The Gold Seal of Approval® from The Joint Commission®.

To learn more, visit alvitacare.com

Share article on social media or email:

Soul Surgery Launches Addiction Treatment Program Specific to Native American Community


We want to make a real difference and change people’s lives, and our new Sacred Soul program is a game changer and helps our entire community combat this massive problem.

Soul Surgery, a Scottsdale-based leading integrative medicine addiction center for those suffering from drug and alcohol addiction and mental health challenges, launched a new addiction recovery program to specifically service the Native American community, called Sacred Soul. The program has been in development for six months and has proven to be an overwhelming success.

Sacred Soul follows the proven method that has been developed at Soul Surgery including full detox programs and inpatient and outpatient therapies but also includes traditional Native American healing practices such as smudging, talking circles, red road groups, cultural connecting workshops, and more.

“Many of the existing treatment programs and facilities designed specifically for the Native American population do not provide the level of care necessary to remove the physical and mental obsession behind addiction,” said John Mulligan, CEO of Soul Surgery. “We want to make a real difference and change people’s lives, and our new Sacred Soul program is a game changer and helps our entire community combat this massive problem.”

These traditions are paired with Soul Surgery’s dual-diagnosis and integrative approach to combating addiction, including its Back to Basics intense 7-week transformation, a job skill program, parenting education, IV nutrient therapy, acupuncture, bio sound feedback, fitness training, chiropractic care, massage, and more.

Despite only representing about 2% of the U.S. population, Native Americans have the highest rates of alcohol, marijuana, cocaine, and hallucinogen use disorders and the second highest methamphetamine abuse rates. The CDC reported that from 2019 to 2020, overdose fatalities increased by 39% among Native Americans.

Soul Surgery’s unique blend of cutting-edge, evidence-based treatment, upscale facilities and passionate and professional staff teach clients the Back To Basic steps of removing the physical and mental obsession to become recovered. Treatments are offered at Soul Surgery’s state-of-the-art rehabilitation centers and behavioral health facilities located in North Scottsdale. Each location provides luxurious accommodations in a setting removed from the stresses of daily life. The necessary structure for recovery is balanced with individual opportunities for reflection and growth in an ideal environment.

For more information, please visit http://www.soulsurgery.com or call 480-637-2474.

About Soul Surgery

Scottsdale-based Soul Surgery is a premier integrative medicine addiction center offering medical detox, outpatient and residential treatment programs for alcohol and drug addiction recovery and mental health challenges. Joint Commission-accredited Soul Surgery is a leader in fentanyl addiction and stands out as the leading dual diagnosis treatment facility in the nation.

Share article on social media or email:

Senior Global Regulatory Affairs Executive, Dr. Daniela Drago, Joins NDA Partners as Expert Consultant


News Image

Dr. Drago’s extensive global regulatory experience will be valuable to our clients developing biologics, cell and gene therapy products, and small molecules.

NDA Partners’ General Manager, Eric Fish, announced today that Dr. Daniela Drago, a senior global regulatory affairs executive, has joined the firm as an Expert Consultant. Dr. Drago is a regulatory affairs executive with a history of accomplishments spanning pharmaceutical, biotech, and academic roles. She has held senior global regulatory and medical affairs positions at Biogen, Roche, Vifor Pharma, Reckitt Benckiser, Aurion Biotech, and Bausch & Lomb. She was formerly an Associate Professor at George Washington University’s School of Medicine where she redesigned and led the regulatory affairs program. Currently, she is an Adjunct Faculty for the University of California, San Francisco (UCSF), American Course on Drug Development and Regulatory Sciences (ACDRS), and the University of Basel, European Center of Pharmaceutical Medicine (ECPM).

Dr. Drago has significant global expertise in the development of small molecules, biologics, cell and gene therapies, and combination products in multiple rare and common disease areas, including ophthalmology, neurology, immunology, and oncology. “Dr. Drago’s extensive global regulatory experience will be valuable to our clients developing biologics and cell and gene therapy products, and small molecules. We are pleased to welcome her to NDA Partners and our Biologics Practice,” said Dr. Ellen Feigal, who leads the firm’s Biologics Development Practice.

Dr. Drago serves on the Regulatory Affairs Committee of the American Society of Gene and Cell Therapy (ASGCT), the Regulatory Affairs Certification Board of Directors, and the Executive Committee of ACDRS. She is a TOPRA Fellow (FTOPRA) and a Fellow of the Regulatory Affairs Professional Society (FRAPS). She has received several awards, including the TOPRA Award for Regulatory Excellence and the RAPS Community Leadership Award. She received her PhD in chemistry from the Swiss Federal Institute of Technology (ETH) in Zurich and MS in Chemistry from the University of Messina in Italy.

About NDA Partners

NDA Partners, a ProPharma Group company, is a life sciences management consulting and contract development organization focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, product development program design and management, expert consulting, functional teams, project-based solutions, and clinical trial design and management.

Contact

Eric Fish, General Manager

Office: 540-738-2550

FishEric@ndapartners.com

Share article on social media or email:

ScribeAmerica’s ambient AI scribe excels in metrics of recent KLAS report


Speke is an ambient AI scribe that seamlessly integrates into providers’ workflow so they can decrease time spent on EHR documentation and more time spent with their patients.

Speke, an ambient AI scribe created by ScribeAmerica, has recently been the subject of a KLAS Emerging Technology Spotlight report. The report from KLAS – a leading healthcare IT research firm that provides accurate, honest and impartial insights – describes the experiences of healthcare organizations using Speke, with 100% of those surveyed indicating they were satisfied and would use Speke again.

Speke, is an AI-powered, voice-enabled documentation assistant, that seamlessly works with a provider’s workflow to complete documentation during patient encounters. Supported by ScribeAmerica’s renowned medical scribes, Speke reduces provider administrative loads so that they can spend more time at the patient’s bedside.

The KLAS report examines the customer experience and overall satisfaction using Speke. Customers gave Speke high performance grades in all categories. In the report, KLAS offered the following insights:

100% of customers were satisfied or highly satisfied working with Speke.

100% of customers saw outcomes from working with Speke, with 20% seeing immediate outcomes.

Customer benefits include decreased physician burnout, increased capacity and available time with patients, and an increase in patient engagement.

In four key performance indicators – supporting integration goals, functionality, executive involvement and likelihood to recommend – Speke received “A” grades. 100% of those customers said they would purchase Speke again.

The report states: “With scribes ensuring back-end accuracy and quality, Speke’s AI feature uses a recording to automate the documentation process during patient visits, decreasing physician burnout. Speke users highly value having both synchronous and asynchronous functionality.”

With staffing shortages and provider burnout on the rise, clinicians need innovative solutions that shift them away from the computer and back to the bedside. Speke is an ambient AI scribe that seamlessly integrates into providers’ workflow so they can decrease time spent on EHR documentation and more time spent with their patients.

To download the KLAS report, click here.

About ScribeAmerica

For nearly 20 years, ScribeAmerica has been the nation’s largest and most progressive medical scribe company. Serving over 3,500 partners in all 50 states, our dedicated teams custom design, hire, train and manage programs specific to our partners’ needs.

Share article on social media or email:

The Bluntness, Inc. Debuts eBook Revealing Success Secrets To Starting a Cannabis Business in NY


The Bluntness Debuts eBook Revealing Success Secrets To Starting a Cannabis Business in NY

“The Guide to Starting a Cannabis Business will provide educational content, best practices, common mistakes, & other operational insights to those interested in the budding cannabis industry in emerging markets such as NY, NJ, CT and beyond,” added Gregory Frye, Executive Editor, TheBluntness.com.

The Bluntness, Inc., one of the fastest growing independent digital media companies and 360° lifestyle brands that explores, examines and elevates cannabis & psychedelic culture, community & commerce, today announced the debut of its free business eBook, The Guide to Starting a Cannabis Business.

The Guide to Starting a Cannabis Business, is poised to become the go-to business blueprint for aspiring cannabis entrepreneurs looking to unlock the hidden benefits of planning for success in the highly competitive and highly regulated cannabis industry taking shape in NY and elsewhere.

Developed by The Bluntness’ in-house Content Studio, The Guide to Starting a Cannabis Business proves that it is one thing to talk about and cover the cannabis industry and truly another to be an active participant of it – e.g. acquire a license, raise capital, understand the legal complexities & ramifications of compliance – as well as the universal measures that accompany running a successful business of any kind, have a vision, execute goals, establish processes and the steps and stamina necessary to achieve it.

The Guide features insights and expertise from well-respected and successful cannabis entrepreneurs, multi-state operators, policy makers and advocates, among others, providing useful knowledge, guidance and inspiration that aspiring cannabis business owners need to create unique and individual success plans in this rapidly evolving, exciting but challenging industry.

By capturing and sharing real-world advice from those who have built successful medical or recreational cannabis businesses, The Bluntness expertly and painstakingly curates their collective wisdom into one compelling and comprehensive blueprint.

“With adult-use cannabis legalization spreading in the United States and especially in our hometown of New York City, many aspiring cannapreneurs want to know – how to get into the industry and what does it take to make a cannabis business successful?” said Harrison Wise, Chairman and Publisher of The Bluntness, Inc. “To help address these and so many other questions of this nature, our editorial team have examined the regulations, spoken to the policy makers, the advocates, the trailblazers, the investors, the operators, the manufacturers, the cultivators, the legacy community and more, in an effort to curate and compile a comprehensive asset of best practices and guidance – to reveal proven success strategies and secrets to help aspiring cannabis entrepreneurs navigate and capitalize on this huge opportunity.”

Check out a few excerpts from the Guide below:


  • “The end of the Green Rush is the start of a real industry with surviving operators becoming even stronger, less reliant on speculation and more focused on performance,” explains Brian Mitchell, CEO, Shryne Group, which owns Stiiizy and a portfolio of premium cannabis brands. “Out of all the potential green rush mistakes, perhaps the most reckless move is to start a cannabis business with no relevant expertise. A lot of people who hope to simply “cash in” are in for a very unpleasant surprise, even in a stable market.”
  • “Don’t churn and burn your employees. Pay growers what they are worth. Most importantly, listen to what your master grower tells you,” says cannabis consultant Darace Smith.
  • “Set the foundation of your branding from the get-go. Decide how you will differentiate yourself in a crowded cannabis market,” shared Harrison Wise, President, Wise Collective and publisher of The Bluntness. “You get one chance to make a first impression. Don’t overlook marketing strategy and brand rollout.”

Download our guide today to find out how to get your business up and running in New York State.

“The Guide to Starting a Cannabis Business will provide educational content, best practices, common mistakes, and other operational insights to people and businesses interested in the budding cannabis industry in emerging markets such as NY, NJ, CT and beyond,” added Gregory Frye, Executive Editor, TheBluntness.com. “The individual and collective knowledge and expertise of the people we cover every day are second to none and we felt there was a real need to harness and share that knowledge and expertise in a way that adds value.”

“The Guide gives the broader cannabis community a single place to access this information and allows our editorial and content teams to provide the same trusted, reliable content on a larger and more impactful scale,” Wise concluded.

The Guide to Starting a Cannabis Business is available for download here.

About The Bluntness

Headquartered in NYC, The Bluntness, Inc., is one of the fastest growing independent digital media companies and 360° lifestyle brand that explores, examines and elevates cannabis & psychedelic culture, community & commerce. Since 2018, The Bluntness has served a sophisticated and engaged audience consisting of millions of motivated, passionate and productive adults who choose to enjoy cannabis and psychedelics as part of a balanced and healthy lifestyle. The Bluntness media’s unique properties and assets include the BLUNTNESS/100, a list of the 100 most influential people in cannabis and psychedelics; The Edge and Flow State podcasts; as well as original interviews, video, photography and events covering topics that appeal to diverse demographics. Visit us at: http://www.thebluntness.com.

Share article on social media or email:

BrightStar Care Ranked Among The Fastest Growing Private Companies on the Inc. 5000 Annual List


BrightStar Care, the leading home care and medical staffing franchise with more than 365 locally owned and operated locations nationwide, revealed today that it made the annual Inc. 5000, the most prestigious ranking of the fastest-growing private companies in America. The list represents a one-of-a-kind look at the most successful companies within the economy’s most dynamic segment—its independent businesses. BrightStar Care ranked No. 4718 on the Inc. 5000 list and had three-year revenue growth of 89%, according to Inc.

“BrightStar Care has held a steady presence on Inc.’s 5000 List for over a decade. As our business and operations continue to grow into new markets and territories throughout the country, we’re honored to achieve this prestigious recognition,” said Shelly Sun, CEO and Founder of BrightStar Care. “This year, we’re celebrating 20 years of BrightStar Care, and this award is a testament to how well we’ve adapted and pivoted over the years to stay ahead of industry trends, challenges and maintain our success.”

The companies on the 2022 Inc. 5000 have not only been successful but have also demonstrated resilience amid supply chain woes, labor shortages, and the ongoing impact of Covid-19. Among the top 500, the average median three-year revenue growth rate soared to 2,144 percent. Together, those companies added more than 68,394 jobs over the past three years.

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000.

“The accomplishment of building one of the fastest-growing companies in the U.S., in light of recent economic roadblocks, cannot be overstated,” says Scott Omelianuk, editor-in-chief of Inc. “Inc. is thrilled to honor the companies that have established themselves through innovation, hard work, and rising to the challenges of today.”

Over the last year, BrightStar Care has released groundbreaking data studies showcasing the brand’s unmatched clinical outcomes and payer benefits and launched BrightStar Owned, a program dedicated to expanding the brand’s corporate footprint. With these achievements, BrightStar Care is well-positioned to continue its accelerated growth trajectory and affirm its spot as a leader in the home care industry.

About BrightStar Care:

Founded in 2002, BrightStar Care is a national home care agency with more than 365 franchised locations nationwide that provide medical and non-medical in-home care services to clients in their homes and supplemental care staff to businesses. BrightStar Care franchise agencies across the country employ over 15,000 caregivers and 5,700 registered nurses who oversee the care and safety of each individual client. BrightStar Care offers custom medical staffing solutions to corporate entities and holds national accounts with government agencies across distinct patient populations providing healthcare staff anywhere care is needed. Female founded and led by CEO Shelly Sun, BrightStar Care is committed to providing a higher standard of care through its clinical nurse-led care model. As a member of Moving Health Home, BrightStar Care also actively advocates to change federal and state policies that prevent the home from being an accredited clinical care site. More than 95% of BrightStar Care agencies are Joint Commission accredited – the gold standard within the health care industry. BrightStar Care has also been the only national home care franchise to consecutively receive The Joint Commission’s Enterprise Champion for Quality award for the past decade.

About Inc.

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference & Gala is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

Share article on social media or email:

WI Senior Medicare Patrol warns that Medicare marketing scams are common during Open Enrollment


Wisconsin Senior Medicare Patrol

“Beneficiaries who think they may have been wrongfully enrolled in a plan or those who see other potentially suspicious activity can call the SMP program for help.”

The Medicare Open Enrollment Period, which runs October 15 to December 7 each year, is the time when Medicare beneficiaries can join, switch, or drop a plan.

“There are a lot of rules on what insurance agents can and cannot do. Sometimes they break the rules – like cold calling or approaching beneficiaries with whom they have no prior relationship. They’ll come knock on doors or approach people in hallways. They’ll also disguise marketing events – with the purpose of signing people up for their plans – as educational events,” said Ingrid Kundinger, Wisconsin Senior Medicare Patrol Project Manager.

According to the Medicare Communications and Marketing Guidelines, other violations include agents representing themselves as if they’re from Medicare when they’re really not, agents signing beneficiaries up for plans that are supposed to cover specific prescriptions when the plans really don’t, agents requiring attendees at marketing events to provide contact information as a prerequisite for attending, or agents leaving information such as leaflets, flyers, door hangers, etc., on a beneficiary’s car or residence when they did not have an appointment with that Medicare beneficiary.

Agents are allowed to call beneficiaries who have expressly given advanced permission, make unsolicited contact with potential enrollees using conventional mail and other print media (e.g., advertisements) and by email provided it contains an opt-out function, and conduct marketing/sales activities in common areas of health care settings.

“Beneficiaries who think they may have been wrongfully enrolled in a plan or those who see other potentially suspicious activity can call the SMP program for help,” said Kundinger. “Anyone who has questions, concerns, or complaints about potential fraud and abuse issues is invited to call our toll free and confidential helpline at (888) 818-2611, she said. “We also have excellent information on our website (http://www.smpwi.org) or our Facebook or LinkedIn pages.”

The Senior Medicare Patrol mission is to empower and assist Medicare beneficiaries, their families, and caregivers on how to prevent, detect, and report health care fraud, abuse, and errors through outreach, counseling, and education. The Wisconsin Senior Medicare Patrol program covers 72 counties and 11 federally recognized tribes with educational messages and outreach. The program engages and supports an active team, statewide, to help in mission delivery.

The Wisconsin Senior Medicare Patrol program is housed at the Greater Wisconsin Agency on Aging Resources (GWAAR).

Share article on social media or email:

All 32 NFL Quarterbacks Unite to Raise Money to Fight Against Pediatric Cancer


New Broncos Quarterback Russell Wilson signed helmet to benefit Starr Children’s Fund

“Helmets for Heroes is always a very special fundraiser for me. I hope that we can raise more money for children this year than ever before,” said Cherry Starr.

All 32 starting NFL quarterbacks, along with a few well-known retired NFL quarterbacks, have joined together again this September to raise money for pediatric cancer. Each quarterback donated his own signed helmet to be auctioned off as part of the Starr Children’s Fund Helmets for Heroes online auction, which opens on Sept. 7 at 7:00 am CT.

Money raised will benefit the Starr Children’s Fund, which supports research efforts that impact the lives of pediatric cancer patients.

After learning that of the billions of dollars spent annually on cancer research and treatment only 4% benefits childhood cancer, legendary quarterback Bart Starr and his wife, Cherry Starr, established the Starr Children’s Fund in collaboration with the Vince Lombardi Cancer Foundation (VLCF). To date, the Starrs have helped raise over $16 million to help fight cancer.

“Helmets for Heroes is always a very special fundraiser for me,” said Cherry Starr. “I hope that we can raise more money for children this year than ever before.”

Before he passed away at the age of 85 in 2019, Bart Starr used to write letters at the beginning of the season to every quarterback in the league wishing them good luck. He called them his ‘kick-off notes.’ Since then, Cherry has been continuing the tradition and writing letters to all 32 starting NFL quarterbacks herself.

“I wrote a letter to every quarterback in the NFL to continue the kick-off notes that Bart used to write,” she said. “I’m proud that all 32 of them are participating for the fourth year in a row.”

The Starr Children’s Fund Helmets for Heroes auction closes on Sept. 14 at 7:00 p.m. CT. To learn more and bid, visit lombardifoundation.org/helmetsforheroes

About Starr Children’s Fund

Bart Starr’s legacy on the football field matched his charitable legacy. After Coach Vince Lombardi passed away from colon cancer in 1970, Bart and Cherry Starr graciously accepted the role of honorary chairpersons of the first annual Vince Lombardi Memorial Golf Classic and served the foundation for 44 years. They contributed to raising more than $16 million to help fight cancer. In 2017, in collaboration with the Vince Lombardi Cancer Foundation, they introduced the Starr Children’s Fund, which is dedicated to raising funds to support pediatric cancer research and treatment.

Share article on social media or email: